NPR2
NPR2 (natriuretic peptide receptor 2, also known as natriuretic peptide receptor B, NPRB, GC-B, ANPb, ANPRB or GUCY2B) is a membrane-bound guanylate cyclase receptor for C-type natriuretic peptide. Ligand binding activates its guanylyl cyclase activity, and the receptor is linked to skeletal growth. Browse Assay Genie's current range of NPR2 research reagents below, or read on for the biology behind the target.
NPR2 is the receptor for the C-type natriuretic peptide hormone, NPPC/CNP. It has guanylate cyclase activity, and this activity increases greatly once the receptor binds its ligand. UniProt annotates the protein as possibly playing a role in the regulation of skeletal growth. NCBI Gene describes it as the primary receptor for C-type natriuretic peptide (CNP).
The NPR2 gene encodes natriuretic peptide receptor B, one of two integral membrane receptors for natriuretic peptides; the other is NPR1. Both receptors have five functional domains: an extracellular ligand-binding domain, a single membrane-spanning region, an intracellular protein kinase homology domain, a helical hinge region involved in oligomerisation, and a carboxyl-terminal guanylyl cyclase catalytic domain. The protein localises to the cell membrane and belongs to the adenylyl cyclase class-4/guanylyl cyclase family. HGNC places it in the transmembrane guanylate cyclases group. Researchers studying the NPR2 protein often compare it with NPR1 and NPR3 to separate the signalling of different natriuretic peptide receptors.
The gene has carried several names, including GUCY2B, natriuretic peptide receptor B and atrionatriuretic peptide receptor B. Mutations in the NPR2 gene cause acromesomelic dysplasia, Maroteaux type, which is the origin of the AMDM alias. This disease link makes NPR2 a reference point for work on CNP signalling and skeletal development.
NPR2 is the receptor for CNP and may regulate skeletal growth, so it is studied in bone development and growth control.
Mutations in NPR2 cause acromesomelic dysplasia, Maroteaux type, making it central to work on the genetics of this disorder.
Ligand binding greatly increases the guanylyl cyclase activity of NPR2, which makes it a model for receptor-coupled guanylyl cyclase signalling.
NPR2 is one of two natriuretic peptide receptors with guanylyl cyclase domains, supporting comparison with NPR1 and the CNP axis.
NPR2 is the receptor for C-type natriuretic peptide (NPPC/CNP). When the ligand binds, the receptor's guanylyl cyclase activity rises greatly. UniProt notes it may play a role in regulating skeletal growth. It sits in the cell membrane.
NPR2 is also called natriuretic peptide receptor B, NPRB, GC-B, ANPb, ANPRB and GUCY2B. Earlier names include atrionatriuretic peptide receptor B. The AMDM alias refers to acromesomelic dysplasia, Maroteaux type, the disorder linked to mutations in this gene.
Mouse and rat both have an Npr2 ortholog. In humans, NPR2 mutations cause acromesomelic dysplasia, Maroteaux type. Check the datasheet of any product for its validated reactivity.
Other natriuretic peptide receptors that share the family and signalling context of NPR2.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P20594; product specifications from Assay Genie datasheets.